Actively Recruiting
Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
Led by Yale University · Updated on 2025-12-26
66
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is an examination of the influence of cooling components of WS-3, WS-23, and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults.
CONDITIONS
Official Title
Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Able to read and write
- Current e-cigarette user
- Urine cotinine level 200 ng/ml
- Willing to abstain from tobacco/nicotine use for 2 hours before sessions
You will not qualify if you...
- Current use of non-prescription substances other than nicotine, marijuana, or alcohol
- Significant current medical or psychiatric condition
- Known allergy to propylene glycol
- Pregnant or breastfeeding
- Uncontrolled asthma
- Allergy to nuts or e-liquid flavorings
- Current marijuana vaping and symptoms of E-cigarette or Vaping Use Associated Lung Injury (EVALI)
- Dislike of menthol flavor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
JB Pierce Lab
New Haven, Connecticut, United States, 06519
Actively Recruiting
Research Team
D
Danielle Davis, PhD
CONTACT
W
Wei Li, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
18
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here